Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / OPNT - Opiant Pharmaceuticals Inc. (OPNT) CEO Roger Crystal On Q4 2021 Results - Earnings Call Transcript


OPNT - Opiant Pharmaceuticals Inc. (OPNT) CEO Roger Crystal On Q4 2021 Results - Earnings Call Transcript

Opiant Pharmaceuticals, Inc. (OPNT) Q4 2021 Earnings Conference Call March 15, 2022 4:30 PM ET Company Participants Ben Atkins - Vice President, Communications and Investor Relations Roger Crystal - President and Chief Executive Officer Matt Ruth - Chief Commercial Officer David O'Toole - Chief Financial Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald Carl Byrnes - Northland Capital Markets David Bautz - Zacks Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide. Presentation Operator 00:03 Greetings, and welcome to the Opiant Pharmaceuticals Fourth Quarter and Full-Year 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator

For further details see:

Opiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal On Q4 2021 Results - Earnings Call Transcript
Stock Information

Company Name: Opiant Pharmaceuticals Inc.
Stock Symbol: OPNT
Market: NASDAQ

Menu

OPNT OPNT Quote OPNT Short OPNT News OPNT Articles OPNT Message Board
Get OPNT Alerts

News, Short Squeeze, Breakout and More Instantly...